We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




New Quality Control Reference for Monitoring NGS-Based Tumor Profiling Assays

By LabMedica International staff writers
Posted on 20 Jul 2015
Print article
Image: The Seraseq Solid Tumor Mutation Mix kit (Photo courtesy of SeraCare).
Image: The Seraseq Solid Tumor Mutation Mix kit (Photo courtesy of SeraCare).
A newly released kit was designed to enable genomics researchers and drug developers to evaluate the performance of next generation sequencing (NGS)-based tumor profiling assays.

The SeraCare Life Sciences (Milford, MA, USA) Seraseq Solid Tumor Mutation Mix-I reference material is a mixture of biosynthetic target genes with specific engineered mutations in a wild-type background of well-characterized genomic DNA and is compatible with all major cancer hotspot oncology panels and NGS platforms on the market today. The reference matrix contains a mixture of mutations in key oncogenes and tumor suppressor genes and is intended as a quality control standard for translational and disease research testing.

This "for research use only" version includes 26 major cancer hotspot genes, all at 20% allelic frequency and quantified using digital PCR to ensure highest accuracy. The material is stable for two years under recommended storage conditions, and can undergo ten freeze-thaw cycles without any degradation of performance.

"SeraCare's extensive background and experience with the manufacture of quality reference and validation materials under cGMP ISO standards has enabled us to develop the Seraseq Solid Tumor Mutation Mix," said Dr. Russell Garlick, CSO at SeraCare. "This technology allows almost unlimited breadth of mutations and can be accurately "tuned" to specific allelic frequencies because we have incorporated digital PCR in the manufacturing. With this product, we can partner with in vitro diagnostics developers and clinical labs to offer a powerful performance tracking tool for their NGS tumor profiling assays."

Related Links:

SeraCare Life Sciences


New
Gold Member
Thyroid Stimulating Hormone Assay
TSH EIA 96 Test
Unit-Dose Packaging solution
HLX
New
Thyroid ELISA Kit
AESKULISA a-TPO
New
Adenovirus Detection Kit
REALQUALITY RQ-ADENO

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Molecular Diagnostics

view channel
Image: The bowel cancer breakthrough could result in better treatment outcomes (Photo courtesy of 123RF)

New RNA Molecules Can Help Predict Bowel Cancer Return Recurrence

Colorectal cancer accounts for 10% of all cancer-related deaths worldwide and was ranked as the second most common cause of cancer death in the United States in 2022. Currently, clinicians face diagnostic... Read more

Hematology

view channel
Image: QScout CBC will give a complete blood count in 2 minutes from fingerstick or venous blood (Photo courtesy of Ad Astra Diagnostics)

Next Gen CBC and Sepsis Diagnostic System Targets Faster, Earlier, Easier Results

Every hour is critical in protecting patients from infections, yet there are currently limited tools to assist in early diagnosis before patients reach a hospital. The complete blood count (CBC) is a common... Read more

Microbiology

view channel
Image: The InfectoSynovia test has the potential to revolutionize the diagnosis of periprosthetic joint infection (Photo courtesy of 123RF)

High-Accuracy Bedside Test to Diagnose Periprosthetic Joint Infection in Five Minutes

Periprosthetic joint infection (PJI) represents a significant global issue that is worsening as the number of joint replacements increases due to aging populations. In the United States alone, the anticipated... Read more

Pathology

view channel
Image

AI-Based Method Shows Promise for Pathological Diagnosis of Hereditary Kidney Diseases

Alport syndrome is a hereditary kidney disorder characterized by kidney dysfunction, sensorineural hearing loss, and ocular abnormalities. Early in the disease, patients experience hematuria, which is... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.